3rd Quarter - Report

MARS, INCORPORATED for MARS, INCORPORATED

Firm
Client
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade policy, including with China and the EU; international restrictions on the sales of packaged food.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Civil Rights/Civil Liberties CIV

Support for investments in disadvantaged communities that have fewer resources to manage the cost of climate change, including rising energy costs as a result of policy changes; support for additional resources for food and nutrition benefits programs during COVID.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Agriculture AGR

Appropriations funding for international aid and development programs, including ILAB and USAID; support for policies to incentivize agricultural producers to reduce greenhouse gas emissions, such as S. 3894, The Growing Climate Solutions Act of 2020; Funding for international aid related to COVID-19 relief.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Bills named: S. 3894 (116th)

Health Issues HCR

Support for federal resources and prioritization of COVID testing and vaccines.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Energy/Nuclear ENG

Issues related to energy savings and climate change, including U.S. support for Paris Climate Agreement, support for carbon pricing, support for clean energy deployment and resilient infrastructure, and EPA's Clean Power Plan; support for recycling and packaging policies, including S.1982, Save our Seas 2.0 Act.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1982 (116th)

Food Industry (safety, labeling, etc.) FOO

Supporting FDA voluntary guidance on sodium and sodium reduction in the Child Nutrition Program; Preventative oral health; Food ingredient policy; Dietary guidelines; Food Safety Modernization Act (FSMA) funding; Funding for pet food ingredient reviews; support for funding for the Recycling Partnership; support for policies that improve the US recycling infrastructure; inquiries to understand policy proposals to improve the nations recycling infrastructure, such as S.3263, the Break Free from Plastics Pollution Act of 2020. .

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 3263 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.